The latest findings revealed that miR-205 serves as a potential biomarker for the prognosis of advanced NSCLC, and suppression of miR-205 expression decreased A549 cell biological activity by regulating Akt/mTOR/P21 signaling pathway [39]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.